Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1987 3
1988 1
1989 2
1990 2
1991 5
1992 1
1993 1
1994 2
1995 1
1996 4
1997 6
1998 2
1999 2
2004 2
2005 1
2006 1
2007 1
2008 1
2009 1
2010 6
2011 4
2012 4
2013 8
2014 1
2015 3
2016 1
2017 3
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
An official ATS statement: hepatotoxicity of antituberculosis therapy.
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR; ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. Saukkonen JJ, et al. Among authors: gordin fm. Am J Respir Crit Care Med. 2006 Oct 15;174(8):935-52. doi: 10.1164/rccm.200510-1666ST. Am J Respir Crit Care Med. 2006. PMID: 17021358 Review.
Nontuberculous mycobacterial infections.
French AL, Benator DA, Gordin FM. French AL, et al. Among authors: gordin fm. Med Clin North Am. 1997 Mar;81(2):361-79. doi: 10.1016/s0025-7125(05)70522-8. Med Clin North Am. 1997. PMID: 9093233 Review.
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.
Johnson S, Gerding DN, Li X, Reda DJ, Donskey CJ, Gupta K, Goetz MB, Climo MW, Gordin FM, Ringer R, Johnson N, Johnson M, Calais LA, Goldberg AM, Ge L, Haegerich T. Johnson S, et al. Among authors: gordin fm. Contemp Clin Trials. 2022 May;116:106756. doi: 10.1016/j.cct.2022.106756. Epub 2022 Apr 7. Contemp Clin Trials. 2022. PMID: 35398532 Clinical Trial.
Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group; Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, et al. HIV Med. 2015 Apr;16 Suppl 1(0 1):1-9. doi: 10.1111/hiv.12227. HIV Med. 2015. PMID: 25711317 Free PMC article. No abstract available.
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.
Simonsen L, Higgs E, Taylor RJ, Wentworth D, Cozzi-Lepri A, Pett S, Dwyer DE, Davey R, Lynfield R, Losso M, Morales K, Glesby MJ, Weckx J, Carey D, Lane C, Lundgren J; INSIGHT FLU002 and FLU003 Study Groups. Simonsen L, et al. Clin Infect Dis. 2018 Jul 18;67(3):341-349. doi: 10.1093/cid/ciy088. Clin Infect Dis. 2018. PMID: 29746631 Free PMC article.
Once-daily ceftriaxone for skin and soft tissue infections.
Gordin FM, Wofsy CB, Mills J. Gordin FM, et al. Antimicrob Agents Chemother. 1985 Apr;27(4):648-9. doi: 10.1128/AAC.27.4.648. Antimicrob Agents Chemother. 1985. PMID: 4004197 Free PMC article. Clinical Trial.
71 results